Gillen Oarbeascoa

Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) following treatment with tisagenlecleucel

R Rojas, Ignacio Gómez‐Centurión, Rebeca Bailén et al. · Clinical Case Reports · 2022 · 39 citations · Full text

Clinical Immunology, Immunodeficiencies, Immunology +22

Short Tandem Repeats (STRs) as Biomarkers for the Quantitative Follow-Up of Chimerism after Stem Cell Transplantation: Methodological Considerations and Clinical Application

Almudena Navarro‐Bailón, Diego Carbonell, Asunción Escudero et al. · Genes · 2020 · 33 citations · Full text

Cell Therapy, Genetics, Transplantation Medicine +23

Retrospective Multicenter Study of Extracorporeal Photopheresis in Steroid-Refractory Acute and Chronic Graft-versus-Host Disease

Gillen Oarbeascoa, Marı́a Luisa Lozano, Luisa Guerra et al. · Biology of Blood and Marrow Transplantation · 2020 · 28 citations · Full text

Chronic Gvhd, Ecp Therapy, Transplantation +12

Recent Bendamustine Treatment before Apheresis Has a Negative Impact on Outcomes in Patients with Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy

Gloria Iacoboni, Ana África Martín López, Katarzyna Aleksandra Jalowiec et al. · Blood · 2022 · 28 citations

Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation

Paula Muñiz, Cristina Andrés-Zayas, Diego Carbonell et al. · Frontiers in Immunology · 2022 · 25 citations · Full text

Genetics, Genetic Epidemiology, Immunology +20